Article Per Year (5 Year)
p-Index From 2021 - 2026
0.61
P-Index
This Author published in this journals
All Journal Ophthalmologica Indonesiana
Hernawita Suharko
Unknown Affiliation
Health Professions Medicine & Pharmacology Public Health

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Surgical Outcomes of Correction of Upper Eyelid Retraction in Thyroid Eye Disease Veda Charissa; Hernawita Suharko
Majalah Oftalmologi Indonesia Vol 47 No 1 (2021): Ophthalmologica Indonesiana
Publisher : The Indonesian Ophthalmologists Association (IOA, Perhimpunan Dokter Spesialis Mata Indonesia (Perdami))

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.35749/journal.v47i1.100163

Abstract

Purpose: to evaluate the outcome of anterior blepharotomy in correcting eyelid retraction in patients with Thyroid Eye Disease (TED). Methods: Literature search was conducted from MEDLINE database through PubMed, Google scholar and ClinicalKey. Outcomes included margin-reflex distance, palpebral fissure height, and upper eyelid margin-superior limbus distance. Results: Sixteen articles were reviewed with a mean follow-up time in the studies varied, ranging from 6 to 61 months. The preoperative and postoperative mean MRDs varied. Although there were different success criteria, success rate for full thickness blepharotomy ranged from 59-93%, comparable with levator recession. The complication rates in 14 studies were less than 20%. Conclusion: Full thickness anterior blepharotomy and Müller muscle and levator recession, are safe and effective in correcting upper eyelid retraction in patients with TED. The anterior blepharotomy is a relatively quick and simple procedure.
MANAGEMENT OF CONJUNCTIVAL MELANOMA ARISING FROM PRIMARY ACQUIRED MELANOMA (PAM) : A CASE REPORT: Poster Presentation - Case Report - Ophthalmologist DYAH TJINTYA SARIKA; Hernawita Suharko
Majalah Oftalmologi Indonesia Vol 49 No S2 (2023): Supplement Edition
Publisher : The Indonesian Ophthalmologists Association (IOA, Perhimpunan Dokter Spesialis Mata Indonesia (Perdami))

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.35749/y1yj9b07

Abstract

Introduction : Conjunctival melanoma (CMM) is a rare but potentially a life threatening ocular malignancy. It is an aggressive pigmented tumor and the recurrence rate may be as high as 51% over 10 years.1,2 Surgical wide local excision of the tumour and cryotherapy are current standard treatment of CMM.3,4 The purpose of this case is to report our successful management of conjunctival melanoma using wide excision and cryotherapy. Case Illustration : A 67-year-old man who presented to our hospital with a large, pigmented lesion arising from inferior and superior fornix conjunctiva in his left eye since 6 months ago. On examination, a massive pigmented tumor sized 25 x 10 x 15 mm, protruding from inferior fornix conjunctiva and sized 7 x 5x 3 mm arising from superior fornix conjunctiva of left eye. The mass was excised with 3 mm free margin from the tumour border confirmed with negative frozen section and followed by cryotherapy and conjunctival reconstruction using oral mucous graft. Histopathology confirmed with invasive conjunctival melanoma arising in PAM with severe atypia and no lymphovascular and perineural metastasis Discussion : Two months after we performed wide excision, cryotherapy and oral mucous graft, no recurrence and conjunctival necrosis at primary site were reported. Conclusion : A local wide excision with ‘no touch technique’, cryotherapy and oral mucous graft confirmed with negative frozen section are the mainstay treatment of CMM and has achieved satisfying functional outcomes. Since the high recurrence rate of CMM, we have to close follow up for the next 3 years
Co-Authors DYAH TJINTYA SARIKA Veda Charissa